Key facts

Since Spire Healthcare was formed in 2007 we have improved our performance across a range of metrics whilst treating an increasing number of patients.

For year ended 31 December 2016

 

Patients 

  • 94.7% of patients are seen within 18 weeks of referral (national standard:92%, NHS 89.7%).
  • Our Net Promoter Score, a measure which aligns our patient satisfaction reporting with the NHS and other providers, improved to 83 (2015:82). 
  • 274,100 patient discharges (in-patient and day-cases) - an increase of 1.5% on 2015 (270,000). 

Consultants 

95% of consultants believe our hospitals go out of their way to make a difference to their working relationship. 

Employees

93% of employees believe what they do at work makes a positive difference.  We provide a wide range of training, and a flexible supportive working environment.  

Payors 

2016 has seen a +9% growth in NHS e-referral admissions.  We deliver value for money, price transparency, patient choice and additional capacity to help relieve pressure on overstretched NHS hospitals. 

Shareholders 

2.5p proposed final dividend per share (+4.2%).  We aim to continue to pay a dividend in line with our policy and to return excess cash to shareholders when available.  

Revenue 

  • £926.4 million, an increase of 4.7% on 2015 (£884.8 million) 
  • £162.0 million Adjusted EBITDAR in 2016, an increase of £1.9 million, or 1.2% (2015:£160.1 million) 

Investment
Over £875 million capital investment in Spire Healthcare since 2007



 

 

 

24
Pathology laboratories within the Spire Healthcare Group (2016)
+8,055
people are employed full time at Spire Healthcare (2016)
+3,800
of the country’s most experienced surgeons and other specialists work with Spire Healthcare (2016)